Purchase Order HHSN261201300240P

<p>The National Cancer Institute awarded a purchase order to Ut-Battelle LLC (Oak Ridge National Laboratory) for $4,260.00 on June 21, 2018, for Radium-223, 5 mCi. Performance is located in Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of December 31, 2018.</p>

<p>The National Cancer Institute awarded a purchase order to UT-Battelle LLC (Oak Ridge National Laboratory) for $22,575.00 on December 3, 2020, for radiopharmaceuticals. Performance is at Oak Ridge, Tennessee, with completion targeted for February 4, 2021. The order is firm fixed price with no small business set-aside.</p>

<p>The National Institute of Biomedical Imaging and Bioengineering awarded a purchase order to Isosolutions Marketing And Management Inc. for a Ge-Ga radionuclide generator, with a ceiling value of $183,608.00 and an award date of August 19, 2024. The order carries firm fixed price terms. Place of performance is Bethesda, Maryland. The ultimate completion date is July 31, 2029.</p>

<p>The National Cancer Institute awarded a purchase order to Mirion Technologies (Capintec), Inc. for $13,142.84 on April 17, 2018, with completion on May 17, 2018. The order procures lab supplies and related equipment for nuclear medicine and radiation detection applications. Place of performance is Florham Park, New Jersey. The award carries no set-aside designation and is priced as firm fixed price.</p>

<p>The National Cancer Institute awarded a purchase order to Sun Nuclear Corp. valued at $13,980 on March 27, 2018, for radiation therapy quality assurance equipment and associated supplies. Place of performance is Bethesda, Maryland. The order carries fixed-price pricing with economic price adjustment and an ultimate completion date of March 26, 2019. No set-aside was used.</p>

<p>The National Cancer Institute awarded a purchase order to Oak Ridge Center For Risk Analysis Inc. for $50,000 on September 20, 2017, to obtain expert information on fallout dosimetry, specifically the interception and retention of radionuclides by vegetation and the transport and movement of radionuclides in the environment. Work is performed in Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of September 19, 2019.</p>

<p>The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. for $219,240.50 on August 27, 2014, with an ultimate completion date of August 26, 2015. No set-aside was used. Performance takes place in Bethesda, Maryland. The order is priced on a firm fixed-price basis. The source does not specify the particular equipment, supplies, or services procured under this order.</p>

<p>The National Cancer Institute issued a purchase order to MR Solutions Americas, LLC valued at $12,150 on September 11, 2018. Place of performance is Bethesda, Maryland. The order is a firm fixed-price commercial item acquisition with no set-aside applied. Ultimate completion is scheduled for October 11, 2018.</p>

<p>The NIH Clinical Center awarded a purchase order to Eckert &amp; Ziegler Eurotope GMBH for $4,850.00 on September 11, 2017, with completion by September 22, 2017. Performance occurs in Bethesda, Maryland. The order procures medical isotopes and isotope generators to support radiopharmaceutical research and nuclear medicine programs at the Clinical Center.</p>

<p>The National Cancer Institute awarded a purchase order to Jala Dose Assessment for $37,000.00 on September 20, 2018 to develop a comprehensive international-based dosimetry method for exposure to radioactive fallout from nuclear detonations. Work is performed in Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of September 19, 2019.</p>